Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Antibody-based Therapies
FDA Grant Rare Pediatric Disease Designation to Omeros’s Antibody for C3 Glomerulopathy
Rare pediatric disease designation allows the company to access priority review from the FDA for a new drug application or biologics licence application.
Medicinal Chemistry
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
3D Cell Culture
MicroQuin’s Space-Based Research Uncovers New Pathways in Cancer Treatment
MicroQuin has teamed up with the International Space Station to explore the behaviour of cancer cells in space and the implications this could have for developing new treatments.
Immunotherapy (Non-Oncology)
Phase II Trial Begins for Recombinant Gelsolin as Immune Regulator in ARDS Patients
BioAegis’s recombinant human plasma gelsolin aims to address the inflammatory complications of ARDS.
.jpg)
Antibody & Protein Engineering
Q&A with Silvia Crescioli, Business Intelligence Creator, The Antibody Society
We catch up with Silvia Crescioli from The Antibody Society to unpack the latest trends and technologies fuelling progress in antibody therapeutic development.
Antibody / Protein Production & Purification
Fast-Track Formulation with Biologics Screening in a Snap
On-demand webinar presented by Ross Walton, Senior Application Scientist for Analytics at Unchained Labs
Stem Cell Therapy
Q&A with Terri Gaskell, Chief Technology Officer, Rinri Therapeutics
We catch up with Terri Gaskell from Rinri Tx to discuss how they are reversing hearing loss using stem cell based regenerative medicine.
NextGen Therapeutics
Historic Islet Cell Transplant Offers Hope for a Permanent Cure for Type 1 Diabetes
A study led by Professor Deng Hongkui at Peking University successfully treated a type 1 diabetes patient by transplanting insulin-producing islet cells derived from the patient's reprogrammed stem cells.
NextGen Therapeutics
Lonza and Vertex Pen Long Term Supply Deal for CASGEVY
Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network.
NextGen Therapeutics
Tackling Tumours from Within: Tumour Reprogramming Offers Hope in Cancer Immunotherapy
A novel gene therapy developed by Asgard Therapeutics and Lund University reprograms tumour cells into cancer-fighting immune cells.